In the early stage of tumor development, androgens such as DHT can combine with androgen receptor with high affinity, and activate the transcription of many downstream target genes after entry nuclear to promote the proliferation and development of androgen-dependent prostate cancer cells (such as 22RV1). This evidence concerns the gene AR and Familial prostate cancer.